Expertise in
7
conditions

Damien Biotti

CHU Purpan
Toulouse, FR 
Expertise in
7
conditions
CHU Purpan
Toulouse, FR 

Overview

Damien Biotti practices practicing medicine in Toulouse, France.

Mr. Biotti is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Optic Neuritis, Multiple Sclerosis (MS), Neuromyelitis Optica, and Transverse Myelitis.

He is actively involved in clinical research, co-authoring 86 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

CHU Purpan
Toulouse, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing SAR442168 to Placebo in Participants With Primary Progressive Multiple Sclerosis (PERSEUS)
A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing SAR442168 to Placebo in Participants With Primary Progressive Multiple Sclerosis (PERSEUS)
Enrollment Status: Completed
Publish Date: January 07, 2026
Intervention Type: Drug
Study Drug: Tolebrutinib
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing SAR442168 to Placebo in Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis
A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing SAR442168 to Placebo in Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis
Enrollment Status: Completed
Publish Date: July 02, 2025
Intervention Type: Drug
Study Drug: Tolebrutinib
Study Phase: Phase 3
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber's Hereditary Optic Neuropathy (LHON)
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber's Hereditary Optic Neuropathy (LHON)
Enrollment Status: Completed
Publish Date: July 16, 2021
Intervention Type: Drug
View 2 Less Clinical Trials

86 Total Publications

Anti-IgLON5 encephalitis is associated with anti-retinal immunological reactivity without retinal alteration.
Anti-IgLON5 encephalitis is associated with anti-retinal immunological reactivity without retinal alteration.
Journal: Journal of translational autoimmunity
Published: January 23, 2026

Frequently Asked Questions about Damien Biotti

Is Damien Biotti a top-rated expert for Optic Neuritis?

MediFind is an objective health platform that identifies experts based on real-world data. Damien Biotti is classified as an Distinguished expert for Optic Neuritis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Damien Biotti participate in research or clinical trials?

Yes. Damien Biotti has published 86 articles and abstracts on conditions like Optic Neuritis. You can view a list of Damien Biotti's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Biotti's expertise for a condition
ConditionClose
    View All 24 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile